Fulgent Genetics FLGT Income Statement (2015-2026)

NASDAQ FLGT
$19.93 +0.12 (+0.61%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Fulgent Genetics Quarterly Income Statement

Periods 45 quarters
Latest Jun 2026

Fulgent Genetics reported revenue of $85.39M and net income of -$29.72M for the quarter ended Jun 2026, up 4.4% year over year. This income statement covers 45 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
227.87M251.67M320.27M125.34M105.66M83.60M66.17M67.85M84.69M70.50M64.48M71.03M71.74M76.21M73.46M81.80M84.07M0.40M71.14M85.39M
Cost of RevenueCost of Rev
43.47M62.13M77.72M60.06M59.56M54.72M47.36M47.28M44.84M45.28M42.38M44.54M44.97M44.37M45.12M47.37M48.56M50.75M49.65M59.71M
Gross Profit
184.40M189.54M242.54M65.28M46.09M12.99M18.81M20.57M39.84M25.23M22.10M26.49M26.77M31.85M28.35M34.44M35.51M32.58M21.49M25.68M
Operating items
Amortization - Intangibles
0.80M0.91M0.91M1.57M2.01M2.01M2.00M2.00M2.00M1.95M2.00M2.00M2.00M2.00M2.00M2.00M2.02M2.03M2.03M2.60M
Research & DevelopmentR&D
6.02M8.20M7.94M10.87M9.86M10.25M10.08M10.72M10.16M10.50M11.43M13.49M11.78M12.11M12.39M13.48M13.86M14.17M14.18M15.23M
Selling, General & AdministrativeSG&A
12.30M22.10M25.77M30.24M26.27M28.79M21.80M17.99M17.50M31.71M21.49M21.33M20.95M24.34M25.29M26.39M23.34M41.65M27.68M27.20M
Restructuring CostsRestructuring
2.90M0.10M-0.03M2.10M1.50M2.60M0.30M
Other Operating ExpensesOther Opex
6.81M8.38M6.89M8.48M9.51M10.52M11.75M11.65M11.97M134.14M10.98M10.59M11.12M11.53M10.46M14.28M11.57M11.50M11.65M19.03M
Operating ExpensesOpex
25.13M38.68M40.61M52.48M45.74M49.54M43.63M40.37M39.63M176.35M43.90M45.40M43.85M47.98M48.14M54.15M50.86M68.82M56.11M61.75M
Operating IncomeOp. Inc
159.27M150.86M201.93M12.79M0.35M17.00M-24.82M-19.80M0.21M-151.12M-21.80M-18.91M-17.08M-16.14M-19.80M-19.71M-15.35M-0.50M-34.62M-36.07M
EBIT
159.27M150.86M201.93M12.79M0.35M17.00M-24.82M-19.80M0.21M-151.12M-21.80M-18.91M-17.08M-16.14M-19.80M-19.71M-15.35M-0.50M-34.62M-36.07M
Non-operating items
Non Operating Interest Expenses
0.07M-0.14M-0.25M0.03M0.01M0.04M0.01M0.02M0.03M0.02M0.02M0.06M
Interest & Investment IncomeInt & Inv Inc
0.50M-0.04M0.04M0.96M1.41M3.22M3.77M5.10M6.47M5.81M7.38M7.71M8.09M8.12M8.02M8.09M7.87M6.94M8.65M6.40M
Other Non Operating IncomeOther Non Op Inc.
0.24M-0.02M-0.01M0.01M0.54M0.01M0.07M0.05M-0.01M-4.02M0.01M0.04M
Non Operating IncomeNon Op. Inc.
6.65M5.92M7.62M7.69M-1.45M8.09M8.07M-1.81M7.84M6.96M8.64M6.38M
Net income details
EBT
159.77M150.82M201.98M13.75M1.76M-33.46M-21.05M-14.70M6.86M-145.20M-14.17M-11.21M-18.53M-8.04M-11.72M-21.52M-7.51M-29.27M-25.98M-29.69M
Tax ProvisionsTaxes
37.55M47.15M48.42M2.70M0.41M-9.39M-5.20M-3.11M20.33M-22.33M-0.33M-2.12M-3.84M-1.84M0.20M-2.30M-0.70M-11.90M-0.70M0.03M
Profit After TaxPAT
122.52M104.34M153.56M11.10M1.72M-24.08M-15.85M-11.59M-13.47M-134.33M-13.85M-9.09M-14.69M-6.19M-11.90M-19.26M-6.83M-23.65M-25.27M-29.72M
Equity Income
Income from Non-Controlling InterestsInc. Minority
-0.30M-0.66M-0.42M-0.44M-0.38M-0.24M-0.51M-0.36M-0.36M-6.18M-0.38M-0.38M-0.05M-0.30M-0.37M-0.30M-0.22M4.35M-0.45M-0.19M
Income from Continuing OperationsIncome (Continuing)
122.22M103.68M153.56M11.05M1.34M-24.08M-15.85M-11.59M-13.47M-122.87M-13.85M-9.09M-14.69M-6.21M-11.92M-19.22M-6.81M-17.37M-25.27M-29.72M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
122.22M103.68M153.56M11.05M1.34M-24.08M-15.85M-11.59M-13.47M-122.87M-13.85M-9.09M-14.69M-6.21M-11.92M-19.22M-6.81M-17.37M-25.27M-29.72M
Income towards Parent CompanyParent Net Inc
122.22M103.68M153.56M11.05M1.34M-24.08M-15.85M-11.59M-13.47M-122.87M-13.85M-9.09M-14.69M-6.21M-11.92M-19.22M-6.81M-17.37M-25.27M-29.72M
Net Income towards Common StockholdersNet Income
122.22M103.68M153.56M11.05M1.34M-24.08M-15.34M-11.23M-13.11M-128.15M-13.46M-8.71M-14.65M-5.89M-11.53M-18.96M-6.61M-23.42M-24.83M-29.53M
Additional items
EPS (Basic)
4.123.535.080.360.04-0.80-0.52-0.38-0.44-4.30-0.45-0.29-0.48-0.19-0.37-0.62-0.21-0.76-0.80-1.05
EPS (Diluted)
3.923.354.920.350.04-0.78-0.52-0.38-0.44-4.30-0.45-0.29-0.48-0.19-0.37-0.62-0.21-0.76-0.80-1.05
Shares Outstanding
29.67M29.41M30.23M30.36M30.17M30.10M29.54M29.81M30.01M29.78M29.77M30.10M30.42M30.23M30.83M30.54M30.75M30.78M30.88M28.00M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
31.17M30.98M31.24M31.19M30.87M30.96M29.54M29.81M30.01M29.78M29.77M30.10M30.42M30.23M30.83M30.54M30.75M30.78M30.88M28.00M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
29.83M30.16M30.33M30.27M29.68M29.44M29.69M29.92M30.04M29.65M29.89M30.26M30.54M30.84M30.62M30.61M30.85M31.08M28.85M27.52M
EBITDA
159.27M150.86M201.93M12.79M0.35M17.00M-24.82M-19.80M0.21M-151.12M-21.80M-18.91M-17.08M-16.14M-19.80M-19.71M-15.35M-0.50M-34.62M-36.07M
Interest ExpensesInt Expense
0.07M-0.14M-0.25M0.03M0.01M0.04M0.01M0.02M0.03M0.02M0.02M0.06M
Tax Rate
23.50%31.26%23.97%19.63%23.56%28.05%24.70%21.16%296.30%15.38%2.31%18.94%20.71%22.82%-1.71%10.69%9.32%40.67%2.71%-0.10%